TruStem Cell Therapy

Founded in 2016 as TruStem Cell Therapy, LLC, this private clinic has positioned itself as a leading U.S. provider of autologous adult stem cell therapy, specializing in neurological, autoimmune, and degenerative conditions using patients’ own bone marrow-derived mesenchymal stem cells (MSCs). With a state-of-the-art surgical center and fully accredited laboratory, TruStem emphasizes minimally manipulative, same-day procedures to align with FDA guidelines for homologous use, harvesting cells via powered bone marrow aspiration for higher yields, sterility, and patient comfort.

The clinic’s patient-centric mission—rooted in hope, empowerment, and innovation—focuses on evidence-based protocols backed by the latest research, refusing treatments for unsupported conditions while integrating a PhD Neuroscientist for optimized harvesting, processing, and administration. Treatments include systemic IV infusion combined with targeted deliveries (e.g., intranasal for brain access, intra-articular for joints), often completed in one day with travel support covering hotel, meals, and transport.

Procedures & Achievements:

TruStem harvests from bone marrow (preferred over adipose for richer MSC content in certain applications), processes in-house without culturing, and administers for conditions like Multiple Sclerosis (gait improvements), Parkinson’s (reduced tremors/medication), Alzheimer’s, stroke, rheumatoid arthritis, osteoarthritis, COPD, and more. Patients report high satisfaction (4.8/5 on Birdefce, 177+ reviews; A+ BBB accredited), with outcomes like restored mobility, reduced inflammation, and enhanced quality of life—e.g., MS patients regaining toe wiggle or stair climbing weeks post-treatment. As of 2025, testimonials highlight rapid benefits in ALS, TBI, and diabetes management, with minimal side effects (soreness/bruising).

While not FDA-approved for these indications (only HSCT for blood disorders is broadly approved), TruStem operates within minimal manipulation rules, earning praise for professionalism and referrals (even from neurologists as patients). Criticisms include high out-of-pocket costs (not insurance-covered) and general FDA cautions on unproven clinics, though no specific violations noted for TruStem. Financing available via LightStream and a results-obsessed approach set it apart.